BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi NQ, Li Y, Zhang Y, Shen N, Qi L, Wang SR, Qi XR. Intelligent "Peptide-Gathering Mechanical Arm" Tames Wild "Trojan-Horse" Peptides for the Controlled Delivery of Cancer Nanotherapeutics. ACS Appl Mater Interfaces 2017;9:41767-81. [PMID: 29161013 DOI: 10.1021/acsami.7b15523] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Tang L, Zhang R, Wang Y, Zhang X, Yang Y, Zhao B, Yang L. A simple self-assembly nanomicelle based on brain tumor-targeting peptide-mediated siRNA delivery for glioma immunotherapy via intranasal administration. Acta Biomater 2023;155:521-37. [PMID: 36384220 DOI: 10.1016/j.actbio.2022.11.013] [Reference Citation Analysis]
2 Zhang Y, Zhang H, Yu H, Ma Y, Hao C, Lin X, Zhang Y, Li Z, Qi X, Zeng J, Shi N. Hot-melt extrusion promotes dissolution, extends “spring-parachute” process and inhibits crystallization in supersaturating microparticle systems. Particuology 2022. [DOI: 10.1016/j.partic.2022.09.007] [Reference Citation Analysis]
3 Vène E, Jarnouen K, Ribault C, Vlach M, Verres Y, Bourgeois M, Lepareur N, Cammas-marion S, Loyer P. Circumsporozoite Protein of Plasmodium berghei- and George Baker Virus A-Derived Peptides Trigger Efficient Cell Internalization of Bioconjugates and Functionalized Poly(ethylene glycol)-b-poly(benzyl malate)-Based Nanoparticles in Human Hepatoma Cells. Pharmaceutics 2022;14:804. [DOI: 10.3390/pharmaceutics14040804] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Zhao T, Liang C, Zhao Y, Xue X, Ma Z, Qi J, Shen H, Yang S, Zhang J, Jia Q, Du Q, Cao D, Xiang B, Zhang H, Qi X. Multistage pH-responsive codelivery liposomal platform for synergistic cancer therapy. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01383-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Teixeira S, Carvalho MA, Castanheira EMS. Functionalized Liposome and Albumin-Based Systems as Carriers for Poorly Water-Soluble Anticancer Drugs: An Updated Review. Biomedicines 2022;10:486. [DOI: 10.3390/biomedicines10020486] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Zorko M, Jones S, Langel Ü. Cell-penetrating peptides in protein mimicry and cancer therapeutics. Adv Drug Deliv Rev 2022;180:114044. [PMID: 34774552 DOI: 10.1016/j.addr.2021.114044] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 16.0] [Reference Citation Analysis]
7 Zorko M, Langel Ü. Cell-Penetrating Peptides. Methods Mol Biol 2022;2383:3-32. [PMID: 34766279 DOI: 10.1007/978-1-0716-1752-6_1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
8 Li Z, Liu C, Li C, Wang F, Liu J, Zheng Z, Wu J, Zhang B. Irinotecan/scFv co-loaded liposomes coaction on tumor cells and CAFs for enhanced colorectal cancer therapy. J Nanobiotechnology 2021;19:421. [PMID: 34906155 DOI: 10.1186/s12951-021-01172-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Li Y, Zhang C, Li G, Deng G, Zhang H, Sun Y, An F. Protease-triggered bioresponsive drug delivery for the targeted theranostics of malignancy. Acta Pharm Sin B 2021;11:2220-42. [PMID: 34522585 DOI: 10.1016/j.apsb.2021.01.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Kong X, Xu J, Yang X, Zhai Y, Ji J, Zhai G. Progress in tumour-targeted drug delivery based on cell-penetrating peptides. J Drug Target 2021;:1-15. [PMID: 33944641 DOI: 10.1080/1061186X.2021.1920026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Lima PHC, Butera AP, Cabeça LF, Ribeiro-Viana RM. Liposome surface modification by phospholipid chemical reactions. Chem Phys Lipids 2021;237:105084. [PMID: 33891960 DOI: 10.1016/j.chemphyslip.2021.105084] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
12 Hua D, Tang L, Wang W, Tang S, Yu L, Zhou X, Wang Q, Sun C, Shi C, Luo W, Jiang Z, Li H, Yu S. Improved Antiglioblastoma Activity and BBB Permeability by Conjugation of Paclitaxel to a Cell-Penetrative MMP-2-Cleavable Peptide. Adv Sci (Weinh) 2021;8:2001960. [PMID: 33552853 DOI: 10.1002/advs.202001960] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
13 Kurrikoff K, Langel Ü. Recent CPP-based applications in medicine. Expert Opinion on Drug Delivery 2019;16:1183-91. [DOI: 10.1080/17425247.2019.1665021] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
14 Shi N, Wang S, Zhang Y, Huo J, Wang L, Cai J, Li Z, Xiang B, Qi X. Hot melt extrusion technology for improved dissolution, solubility and “spring-parachute” processes of amorphous self-micellizing solid dispersions containing BCS II drugs indomethacin and fenofibrate: Profiles and mechanisms. European Journal of Pharmaceutical Sciences 2019;130:78-90. [DOI: 10.1016/j.ejps.2019.01.019] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
15 Klimpel A, Lützenburg T, Neundorf I. Recent advances of anti-cancer therapies including the use of cell-penetrating peptides. Curr Opin Pharmacol 2019;47:8-13. [PMID: 30771730 DOI: 10.1016/j.coph.2019.01.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
16 Langel Ü. Therapeutic Potential of CPPs. CPP, Cell-Penetrating Peptides 2019. [DOI: 10.1007/978-981-13-8747-0_12] [Reference Citation Analysis]
17 Yu M, Li X, Huang X, Zhang J, Zhang Y, Wang H. New Cell-Penetrating Peptide (KRP) with Multiple Physicochemical Properties Endows Doxorubicin with Tumor Targeting and Improves Its Therapeutic Index. ACS Appl Mater Interfaces 2019;11:2448-58. [DOI: 10.1021/acsami.8b21027] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
18 Qu D, Wang L, Qin Y, Guo M, Guo J, Huang M, Liu Y, Liu C, Li H, Chen Y. Non-triggered sequential-release liposomes enhance anti-breast cancer efficacy of STS and celastrol-based microemulsion. Biomater Sci 2018;6:3284-99. [DOI: 10.1039/c8bm00796a] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]